financetom
Business
financetom
/
Business
/
Prog Q3 Non-GAAP Earnings Rise, Revenue Falls; Annual Outlook Revised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Prog Q3 Non-GAAP Earnings Rise, Revenue Falls; Annual Outlook Revised
Oct 22, 2025 5:15 AM

07:59 AM EDT, 10/22/2025 (MT Newswires) -- Prog Holdings ( PRG ) reported Q3 non-GAAP earnings Wednesday of $0.90 per diluted share, up from $0.77 a year earlier.

Analysts polled by FactSet expected $0.74.

Revenue for the quarter ended Sept. 30 was $595.1 million, compared with $606.1 million a year earlier.

Analysts polled by FactSet expected $586.1 million.

For Q4, the company expects non-GAAP EPS from continuing operations of $0.55 to $0.65 on revenue of $575 million to $590 million. Analysts are looking for $0.67 and $599.5 million, respectively.

For 2025, Prog said it now expects non-GAAP EPS from continuing operations of $3.35 to $3.45 on revenue of $2.41 billion to $2.44 billion. Analysts are looking for $3.33 and $2.47 billion, respectively.

Prog previous projected full-year adjusted EPS at $3.20 to $3.35 on revenue of $2.45 billion to $2.50 billion.

The company's shares were up 2.1% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lexaria Bioscience Launches Human Study of DehydraTECH-Processed Tirzepatide
Lexaria Bioscience Launches Human Study of DehydraTECH-Processed Tirzepatide
Oct 10, 2024
10:16 AM EDT, 10/09/2024 (MT Newswires) -- Lexaria Bioscience ( LEXX ) said Wednesday that it started dosing for a human pilot study to assess a DehydraTECH-processed version of tirzepatide from Eli Lilly's ( LLY ) Zepbound in an oral dose. The study comprises up to 10 healthy volunteers, the company said, adding the initial seven-day dosing stage of either...
Tesla Unusual Options Activity
Tesla Unusual Options Activity
Oct 10, 2024
Investors with a lot of money to spend have taken a bullish stance on Tesla . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TSLA,...
Ibex Collaborates With Parloa for Generative Artificial Intelligence Capabilities
Ibex Collaborates With Parloa for Generative Artificial Intelligence Capabilities
Oct 10, 2024
10:15 AM EDT, 10/09/2024 (MT Newswires) -- Ibex (IBEX) said Wednesday it has entered into a partnership with generative artificial intelligence automation provider Parloa. Ibex said it will use Parloa's AI Agent Management Platform as part of the ibex Wave iX solutions suite for clients in North America. Price: 19.52, Change: +0.09, Percent Change: +0.44 ...
Booking Holdings Unusual Options Activity For October 09
Booking Holdings Unusual Options Activity For October 09
Oct 10, 2024
Whales with a lot of money to spend have taken a noticeably bullish stance on Booking Holdings ( BKNG ). Looking at options history for Booking Holdings ( BKNG ) we detected 11 trades. If we consider the specifics of each trade, it is accurate to state that 36% of the investors opened trades with bullish expectations and 18% with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved